Inflammation-related Parameters in Hospitalized Patients with COVID-19: A Retrospective Observational Study

May 31, 2023  |  Vol.9, No.5  |  PP. 601-610  | PDF

AUTHORS:

Bo Kyeung Jung, Department of Laboratory Medicine, Dankook University, College of Medicine, South Korea

Eun Ji Park, Department of Medical Laser, Graduate School of Medicine, Dankook University, South Korea

Sun Gyu Kim, Department of Clinical Laboratory Science, Dongnam Health University, South Korea

Jae Kyung Kim, Department of Biomedical Laboratory Science, Dankook University, South Korea

KEYWORDS:

COVID-19, C-reactive Protein, ESR, Infection, Inflammatory Parameter

Abstract

Assessing biomarker levels during diagnosis may be useful for predicting disease severity when formulating patient care plans. Especially, C-reactive protein (CRP) levels are often used to indicate disease severity and to monitor the response of coronavirus disease (COVID-19) patients to treatment. Similarly, an elevated erythrocyte sedimentation rate (ESR) and white blood cell (WBC) count have been reported as indicators and predictors of disease severity. This retrospective study compared immune indicators, including CRP, ESR, and WBC count, in COVID-19 patients and control group with a standard age of approximately 50 years. Data analysis was performed for patients with COVID-19 hospitalized for two weeks in Gyeonggi Provincial Medical Center Anseong Hospital, South Korea between April and October 2020 and healthy controls who underwent a health checkup in January 2020. Two groups of patients were formed based on the collected data from electronic medical records: younger (<50 years) and older adults (≥50 years). CRP levels and ESR were elevated in both young people and older adults with COVID-19. In contrast, the WBC count were decreased in young people and increased in older adults with COVID-19. Compared to control group, individuals diagnosed with COVID-19 exhibited greater CRP and ESR, with more pronounced differences observed in older adults relative to younger ones. This study provides important data on age-specific immune indicators of COVID-19 by comparing and analyzing immune indicators in individuals with a standard age of approximately 50 years. The findings can also help understand diagnostic test results and characterize viral infection at a specific time, facilitating diagnosis of COVID-19, treatment of the disease, and prediction of patient response. These values may also be useful in assessing and responding to outbreaks of similar viral diseases.

References:

[1] G. Wang, Q. Zhang, C. Wu, F. Wu, B. Yu, J. Lv J, S. Zhang, G. Wu, Y. Zhong, Clinical characteristics of adult fevered COVID-19 patients and predictors for developing severe events, Front Med (Lausanne), (2020) Vol.7, p.324.
DOI: https://doi.org/10.3389/fmed.2020.00324 [2] Lei Liu, Jian-Ya Gao, Wan-mei Hu, Xian-xiang Zhang, Lian Guo, Chun-qiu Liu, Yue-wu Tang, Chun-hui Lang, Fang-zheng Mou, Zheng-jun Yi, Qin-qin Pei, Kai Sun, Jiang-lin Xiang, Jiang-feng Xiao, Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongquing, China, MedRxiv, (2020)
DOI: https://doi.org/10.1101/2020.02.20.20025536
[3] N. Andrews, J. Stowe, F. Kirsebom, S. Toffa, T. Rickeard, E. Gallaghe, C. Gower, M. Kall, N. Groves, A. M. O'Connell, D. Simons, P. B. Blomquist, A. Zaidi, S. Nash, N. Iwani Binti Abdul Aziz, S. Thelwall, G. Dabrera, R. Myers, G. Amirthalingam, S. Gharbia, J. C. Barrett, R. Elson, S. N. Ladhani, N. Ferguson, M. Zambon, C. N. J. Campbell, K. Brown, S. Hopkins, M. Chand, M. Ramsay, J. Lopez Bernal, Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) Variant, N Engl J Med, (2022), Vol.386, No.16, pp.1532-1546.
DOI: https://doi.org/10.1056/NEJMoa2119451
[4] Y. Xian Y, J. Zhang, Z. Bian, H. Zhou, Z. Zhang, Z. Lin, H. Xu, Bioactive natural compounds against human coronaviruses: a review and perspective, Acta Pharm Sin B, (2020), Vol.10, No.7, pp.1163-1174.
DOI: https://doi.org/10.1016/j.apsb.2020.06.002
[5] D. Benvenuto, M, Giovanetti, A. Ciccozzi, S. Spoto, S. Angeletti, M. Ciccozzi, The 2019‐new coronavirus epidemic: evidence for virus evolution, J Med Virol, (2020), Vol.92, No.4, pp.455-459.
DOI: https://doi.org/10.1002/jmv.25688
[6] Y. Du, L. Tu, P. Zhu, M. Mu, R. Wang, P. Yang, X. Wang, C. Hu, R. Ping, P. Hu, T. Li, F. Cao, C. Chang, Q. Hu, Y. Jin, G. Xu, Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study, Am J Respir Crit Care Med, (2020), Vol.201, No.11, pp.1372-1379.
DOI: https://doi.org/10.1164/rccm.202003-0543OC
[7] S. Kazancioglu, A. Bastug, B. O. Ozbay, N. Kemirtlek, H. Bodur, The role of haematological parameters in patients with COVID-19 and influenza virus infection, Epidemiol Infect, (2020), Vol.148, pp.e272.
DOI: https://doi.org/10.1017/S095026882000271X
[8] G. Bolondi, E. Russo, E. Gamberini, A. Circelli, M. C. C. Meca, E. Brogi, L. Viola, L. Bissoni, V. Poletti, V. Agnoletti, Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study, World J Emerg Surg, (2020), Vol.15, No.1, pp.41.
DOI: https://doi.org/10.1186/s13017-020-00323-2
[9] T. I. Hariyanto, K. V. Japar, F. Kwenandar, V. Damay, J. I. Siregar, N. P. H. Lugito, M. M. Tjiang, A. Kurniawan, Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: a systematic review and meta-analysis, Am J Emerg Med, (2021), Vol.41, pp.110-119.
DOI: https://doi.org/10.1016/j.ajem.2020.12.076
[10] G. Lee, M. O. Arcasoy, The clinical and laboratory evaluation of the patient with erythrocytosis, Eur J Intern Med, (2015), Vol.26, No.5, pp.297-302.
DOI: https://doi.org/10.1016/j.ejim.2015.03.007
[11] W. C. Park, I. Seo, S. H. Kim, Y. J. Lee, S. V. Ahn, Association between resting heart rate and inflammatory markers (white blood cell count and high-sensitivity C-reactive protein) in healthy Korean people, Korean J Fam Med, (2017), Vol.38, No.1, pp.8-13.
DOI: https://doi.org/10.4082/kjfm.2017.38.1.8
[12] H. Keski, Hematological and inflammatory parameters to predict the prognosis in COVID-19, Indian J Hematol Blood Transfus, (2021), Vol.37, No.4, pp.534-542.
DOI: https://doi.org/10.1007/s12288-021-01407-y
[13] G. Bivona, L. Agnello, M. Ciaccio, Biomarkers for prognosis and treatment response in COVID-19 patients, Ann Lab Med, (2021), Vol.41, No.6, pp.540-548.
DOI: https://doi.org/10.3343/alm.2021.41.6.540
[14] X. Feng, S. Li, Q. Sun, J. Zhu, B. Chen, M. Xiong, G. Cao, Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis, Front Med (Lausanne), (2020), Vol.7, pp.301.
DOI: https://doi.org/10.3389/fmed.2020.00301
[15] Coronavirus (COVID-19), Republic Korea [homepage on the internet], Republic Korea: cases of COVID-19 in Korea, (2022)
Available from: http://ncov.mohw.go.kr/en/bdBoardList.do? Jun13 (2022)
[16] R. Pastor-Barriuso, B. Pérez-Gómez, M. A. Hernán, M. Pérez-Olmeda, R. Yotti, J. Oteo-Iglesias, J. L. Sanmartín, I. León-Gómez, A. Fernández-García, P. Fernández-Navarro, I. Cruz, M. Martín, C. Delgado-Sanz, N. Fernández de Larrea, J. León Paniagua, J. F. Muñoz-Montalvo, F. Blanco, A. Larrauri, M. Pollán; ENE-COVID Study Group, Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the noninstitutionalized population of Spain, MedRxiv, (2020)
DOI: https://doi.org/10.1101/2020.08.06.20169722
[17] J. Perez-Saez, S. A. Lauer, L. Kaiser, S. Regard, E. Delaporte, I. Guessous, S. Stringhini, A. S. Azman; Serocov-POP Study Group, Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland, Lancet Infect Dis, (2021), Vol.21, No.4, pp.e69-e70.
DOI: https://doi.org/10.1016/S1473-3099(20)30584-3
[18] E. A. K. D. Al-Saadi, M. A. Abdulnabi, Hematological changes associated with COVID‐19 infection, J Clin Lab Anal, (2022), Vol.36, No.1, pp.e24064.
DOI: https://doi.org/10.1002/jcla.24064
[19] Z. Zhu, T. Cai, L. Fan, K. Lou, X. Hua, Z. Huang, G. Gao, Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019, Int J Infect Dis, (2020), Vol.95, pp.332-339.
DOI: https://doi.org/10.1016/j.ijid.2020.04.041
[20] Y. Liu, X. Du, J. Chen, Y. Jin, L. Peng, H. H. X.Wang, M. Luo, L. Chen, Y. Zhao, Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19, J Infectol, (2020), Vol.81, No.1, pp.e6-e12.
DOI: https://doi.org/10.1016/j.jinf.2020.04.002
[21] G. Papadopoulou, E. Manoloudi, N. Repousi, L. Skoura, T. Hurst, T. Karamitros, Molecular and clinical prognostic biomarkers of COVID-19 severity and persistence, Pathogens, (2022), Vol.11, No.3, p.311.
DOI: https://doi.org/10.3390/pathogens11030311
[22] X. Luo, W. Zhou, X. Yan, T. Guo, B. Wang, H. Xia, L. Ye, J. Xiong, Z. Jiang, Y. Liu, B. Zhang, W. Yang, Prognostic value of C-reactive protein in patients with coronavirus 2019, Clin Infect Dis, (2020), Vol.71, No.6, pp.2174-2179.
DOI: https://doi.org/10.1093/cid/ciaa641
[23] J. Peng, D., G. Yuan, X. Deng, Y. Mei, L. Feng, D. Wang, Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID‐19): a multicenter, cross‐sectional study, J Clin Lab Anal, (2020), Vol.34, No.10, pp.e23475.
DOI: https://doi.org/10.1002/jcla.23475
[24] V. Chidambaram, N. L. Tun, W. Z. Haque, M. G. Majella, R. K. Sivakumar, A. Kumar, A. T. Hsu, I. A. Ishak, A. A. Nur, S. K. Ayeh, E. L. Salia, A. Zil-E-Ali, M. A. Saeed, A. P. B. Sarena, B. Seth, M. Ahmadzada, F. F. Haque, P. Neupane, K. H. Wang, T. M. Pu, S. M. H. Ali, M. A. Arshad, L. Wang, S. Baksh, P. C. Karakousis, P. Galiatsatos, Factors associated with disease severity and mortality among patients with COVID-19: a systematic review and meta-analysis. PLOS ONE, (2020), Vol.1, No.11, pp.e0241541.
DOI: https://doi.org/10.1371/journal.pone.0241541
[25] T. Singhal,A review of coronavirus disease-2019 (COVID-19), Indian J Pediatr, (2020), Vol.87, No.4, pp.281-286.
DOI: https://doi.org/10.1007/s12098-020-03263-6
[26] J. Gong, H. Dong, Q. S. Xia, Z. Y. Huang, D. K. Wang, Y. Zhao, W. H. Liu, S. H. Tu, M. M. Zhang, Q. Wang, F. E. Lu, Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study, BMC Infect Dis, (2020), Vol.20, No.1, pp.963.
DOI: https://doi.org/10.1186/s12879-020-05681-5
[27] R. K. Mahat, S. Panda, V. Rathore, S. Swain, L. Yadav, S. P.Sah, The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: a systematic review and meta-analysis, Clin Epidemiol Glob Health, (2021), Vol.11, pp.100727.
DOI: https://doi.org/10.1016/j.cegh.2021.100727
[28] C. Tan, Y. Huang, F. Shi, K. Tan, Q. Ma, Y. Chen, X. Jiang, X. Li, C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early, J Med Virol, (2020), Vol.92, No.7, pp.856-862.
DOI: https://doi.org/10.1002/jmv.25871
[29] J. S. Joen, S. M. Ji, Diagnostic value of procalcitonin and CRP in critically ill patients admitted with suspected sepsis, J Dent Anesthes Pain Med, (2015), Vol.15, No.3, pp.135-140.
DOI: https://doi.org/10.17245/jdapm.2015.15.3.135
[30] Z. Zeng, H. Yu, H. Chen, W. Qi, L. Chen, G. Chen, W. Yan, T. Chen, Q. Ning, M. Han, D. Wu, Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China, Crit Care, (2020), Vol.24, No.1, pp.525.
DOI: https://doi.org/10.1186/s13054-020-03255-0
[31] Henry. B. M, Aggarwal. G, Wong. J, Benoit. S, Vikse. J, Plebani. M & Lippi. G, Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis, The American journal of emergency medicine, (2020), Vol.38, No.9, pp.1722-1726.
DOI: https://doi.org/10.1016/j.ajem.2020.05.073
[32] Y. Han, H. Zhang, S. Mu, W. Wei, C. Jin, C. Tong, Z. Song, Y. Zha, Y. Xue, G. Gu, Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study, Aging (Albany NY), (2020), Vol.12, No.12, pp.11245-11258.
DOI: https://doi.org/10.18632/aging.103372

Citations:

APA:
Jung, B. K., Park, J. E., Kim, S. G., Kim, J. K. (2023). Inflammation-related Parameters in Hospitalized Patients with COVID-19: A Retrospective Observational Study. Asia-pacific Journal of Convergent Research Interchange (APJCRI), ISSN: 2508-9080 (Print); 2671-5325 (Online), KCTRS, 9(5), 601-610. doi: 10.47116/apjcri.2023.05.50.

MLA:
Jung, Bo Kyeung, et al. “Inflammation-related Parameters in Hospitalized Patients with COVID-19: A Retrospective Observational Study.” Asia-pacific Journal of Convergent Research Interchange, ISSN: 2508-9080 (Print); 2671-5325 (Online), KCTRS, vol. 9, no. 5, 2023, pp. 601-610. APJCRI, http://apjcriweb.org/content/vol9no5/50.html.

IEEE:
[1] B. K. Jung, J. E. Park, S. G. Kim, J. K. Kim, “Inflammation-related Parameters in Hospitalized Patients with COVID-19: A Retrospective Observational Study.” Asia-pacific Journal of Convergent Research Interchange (APJCRI), ISSN: 2508-9080 (Print); 2671-5325 (Online), KCTRS, vol. 9, no. 5, pp. 601-610, May 2023.